Practice
Featured experience
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
HNI $2.2 billion acquisition of Steelcase
We are advising HNI on the transaction
Amer Sports $1.3 billion secondary offering
We advised Amer Sports on its SEC-registered secondary offering of ordinary shares
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
ADC Therapeutics secondary offering
We advised ADC Therapeutics on the registered secondary offering of its shares
Roivant Sciences $230 million stock offering
We advised the company on its SEC-registered offering
Precigen $75 million follow-on offering
We advised Precigen on the SEC-registered offering
Morgan Stanley $2 billion subordinated reset notes offering
We advised Morgan Stanley on its SEC-registered global offering
Morgan Stanley $4 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
iQIYI $442 million follow-on offering
We advised the issuer on a follow-on offering of ADSs
Emerson $7.6 billion proposal to acquire National Instruments
We are advising Emerson on the proposal
Cactus $172.5 million follow-on offering
We advised Cactus on the stock offering
Semtech $1.815 billion Sierra Wireless acquisition financing
We advised Semtech on a new term loan facility, the amendment to its revolver and its issuance of convertible notes
SMFG $5.8 billion senior notes offering
We advised SMFG on its offering of TLAC notes